Your browser doesn't support javascript.
loading
Prior Exposure to Angiotensin II Receptor Blockers in Patients With Septic Shock to Individualize Mean Arterial Pressure Target? A Post Hoc Analysis of the Sepsis and Mean Arterial Pressure (SEPSISPAM) Trial.
Demiselle, Julien; Seegers, Valérie; Lemerle, Marie; Meziani, Ferhat; Grelon, Fabien; Megarbane, Bruno; Anguel, Nadia; Mira, Jean-Paul; Dequin, Pierre-François; Gergaud, Soizic; Weiss, Nicolas; Legay, François; Le Tulzo, Yves; Conrad, Marie; Robert, René; Gonzalez, Frédéric; Guitton, Christophe; Tamion, Fabienne; Tonnelier, Jean-Marie; Bédos, Jean-Pierre; Van Der Linden, Thierry; Vieillard-Baron, Antoine; Mariotte, Eric; Pradel, Gaël; Lesieur, Olivier; Ricard, Jean-Damien; Hervé, Fabien; du Cheyron, Damien; Guerin, Claude; Teboul, Jean-Louis; Helms, Julie; Radermacher, Peter; Asfar, Pierre.
Affiliation
  • Demiselle J; Department of Medical Intensive Care, University Hospital of Angers, Angers, France.
  • Seegers V; Service de Biométrie, Institut de Cancérologie de l'Ouest, Centre Paul Papin, Angers, France.
  • Lemerle M; Department of Medical Intensive Care, University Hospital of Angers, Angers, France.
  • Meziani F; Department of Medical Intensive Care, University Hospital of Strasbourg, Nouvel Hôpital Civil, Strasbourg, France.
  • Grelon F; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS, Strasbourg, France.
  • Megarbane B; Medical and Surgical Intensive Care Unit, Le Mans Hospital, Le Mans, France.
  • Anguel N; Department of Medical and Toxicological Intensive Care, Lariboisière University Hospital, University of Paris, INSERM UMRS-1144, Paris, France.
  • Mira JP; Department of Medical Intensive Care, Bicêtre University Hospital, AP-HP, Paris-Saclay University, Le Kremlin Bicêtre, France.
  • Dequin PF; Department of Medical Intensive Care, Cochin University Hospital, Paris, France.
  • Gergaud S; Department of Medical Intensive Care, Tours University Hospital, Tours, France.
  • Weiss N; Department of Surgical Intensive Care, University Hospital of Angers, Angers, France.
  • Legay F; Department of Medical Intensive Care, Georges Pompidou European Hospital, Paris, France.
  • Le Tulzo Y; Department of Medical Intensive Care, Saint Brieuc Hospital, Saint Brieuc, France.
  • Conrad M; Department of Infectious Diseases and Medical Intensive Care, Rennes University Hospital, Rennes, France.
  • Robert R; Department of Medical Intensive Care, Nancy University Hospital, Nancy, France.
  • Gonzalez F; Department of Medical Intensive Care, Université de Poitiers, CHU Poitiers, Poitiers, France.
  • Guitton C; Department of Medical and Surgical Intensive Care, Avicenne Teaching Hospital, Bobigny, France.
  • Tamion F; Department of Medical Intensive Care, Nantes University Hospital, Nantes, France.
  • Tonnelier JM; Department of Medical Intensive Care, Rouen University Hospital, Rouen, France.
  • Bédos JP; Department of Medical Intensive Care, Brest University Hospital, Brest, France.
  • Van Der Linden T; Department of Medical and Surgical Intensive Care, Versailles Hospital, Versailles, France.
  • Vieillard-Baron A; Department of Intensive Care, Saint Philibert hospital, Catholic university of Lille, Lille, France.
  • Mariotte E; Department of Medical and Surgical Intensive Care, Boulogne Billancourt University Hospital, Boulogne Billancourt, France.
  • Pradel G; Inserm U1018, Center for Research in Epidemiology and Population Health (CESP), Faculty of Paris Saclay, Villejuif, France.
  • Lesieur O; Department of Intensive Care, Saint Louis Hospital, Paris, France.
  • Ricard JD; Department of Intensive Care, Avignon Hospital, Avignon, France.
  • Hervé F; Department of Medical and Surgical Intensive Care, La Rochelle Saint Louis Hospital, La Rochelle, France.
  • du Cheyron D; Department of Medico-Surgical Intensive Care, Université de Paris, Assistance Publique - Hôpitaux de Paris, Louis Mourier Hospital, Colombes, France.
  • Guerin C; Department of Medical and Surgical Intensive Care, Quimper Hospital, Quimper, France.
  • Teboul JL; Department of Medical Intensive Care, Caen University Hospital, Caen, France.
  • Helms J; Department of Medical Intensive Care, Edouard Herriot Hospital, Lyon, France.
  • Radermacher P; Department of Medical Intensive Care, Bicêtre University Hospital, AP-HP, Paris-Saclay University, Le Kremlin Bicêtre, France.
  • Asfar P; Department of Medical Intensive Care, University Hospital of Strasbourg, Nouvel Hôpital Civil, Strasbourg, France.
Crit Care Med ; 49(4): e412-e422, 2021 04 01.
Article in En | MEDLINE | ID: mdl-33591012
ABSTRACT

OBJECTIVES:

Individualizing a target mean arterial pressure is challenging during the initial resuscitation of patients with septic shock. The Sepsis and Mean Arterial Pressure (SEPSISPAM) trial suggested that targeting high mean arterial pressure might reduce the occurrence of acute kidney injury among those included patients with a past history of chronic hypertension. We investigated whether the class of antihypertensive medications used before the ICU stay in chronic hypertensive patients was associated with the severity of acute kidney injury occurring after inclusion, according to mean arterial pressure target.

DESIGN:

Post hoc analysis of the SEPSISPAM trial.

SETTING:

The primary outcome was the occurrence of severe acute kidney injury during the ICU stay defined as kidney disease improving global outcome stage 2 or higher. Secondary outcomes were mortality at day 28 and mortality at day 90. PATIENTS All patients with chronic hypertension included in SEPSISPAM with available antihypertensive medications data in the hospitalization report were included. MEASUREMENTS AND MAIN

RESULTS:

We analyzed 297 patients. Severe acute kidney injury occurred in 184 patients, without difference according to pre-ICU exposure to antihypertensive medications. Patients with pre-ICU exposure to angiotensin II receptor blockers had significantly less severe acute kidney injury in the high mean arterial pressure target group (adjusted odd ratio 0.24 with 95% CI [0.09-0.66]; p = 0.006). No statistically significant association was found after adjustment for pre-ICU exposure to antihypertensive medications and survival.

CONCLUSIONS:

Our results suggest that patients with septic shock and chronic hypertension treated with angiotensin II receptor blocker may benefit from a high mean arterial pressure target to reduce the risk of acute kidney injury occurrence.
Subject(s)

Full text: 1 Collection: 01-internacional Health context: 4_TD Database: MEDLINE Main subject: Shock, Septic / Acute Kidney Injury / Angiotensin Receptor Antagonists / Antihypertensive Agents Type of study: Clinical_trials / Etiology_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Crit Care Med Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 4_TD Database: MEDLINE Main subject: Shock, Septic / Acute Kidney Injury / Angiotensin Receptor Antagonists / Antihypertensive Agents Type of study: Clinical_trials / Etiology_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Crit Care Med Year: 2021 Document type: Article